NasdaqGM - Delayed Quote USD
Tectonic Therapeutic, Inc. (TECX)
21.51
-0.89
(-3.97%)
At close: May 30 at 4:00:00 PM EDT
21.51
0.00
(0.00%)
After hours: May 30 at 4:04:10 PM EDT
Insider Purchases Last 6 Months
| 股份 | Transactions | |
|---|---|---|
| Purchases | 1,414,989 | 12 |
| Sales | 500,000 | 1 |
| Net Shares Purchased (Sold) | 914,989 | 13 |
| Total Insider Shares Held | 7.15M | -- |
| % Net Shares Purchased (Sold) | 14.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| 股份 | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SPRINGER TIMOTHY A Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 17.10 per share. | Indirect | 8,550,000 | Apr 7, 2025 |
| MCGUIRE TERRANCE G Director | Sale at price 17.10 per share. | Indirect | 8,550,000 | Apr 7, 2025 |
| SPRINGER TIMOTHY A Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 50.00 - 54.14 per share. | Indirect | 39,999,977 | Feb 5, 2025 |
| LOCHNER DANIEL J. Chief Financial Officer | Purchase at price 54.14 per share. | Direct | 249,964 | Feb 5, 2025 |
| REICIN ALISE S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| LOCHNER DANIEL J. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| MCNAMARA PETER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| SCHWABISH MARC PH.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| RUDDY MARCELLA KUHLMAN M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| SCHWABISH MARC PH.D. Officer | Conversion of Exercise of derivative security at price 2.38 per share. | Direct | 6,426 | Jan 28, 2025 |
| SCHWABISH MARC PH.D. Officer | Conversion of Exercise of derivative security at price 2.38 per share. | Direct | 4,760 | Dec 9, 2024 |
| REICIN ALISE S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 4, 2024 |
| MCNAMARA PETER Officer | Conversion of Exercise of derivative security at price 2.38 per share. | Direct | 8,330 | Dec 3, 2024 |
| SPRINGER TIMOTHY A Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 33.59 per share. | Direct | 10,077,000 | Oct 22, 2024 |
| SPRINGER TIMOTHY A Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 28.16 - 30.87 per share. | Direct | 1,440,829 | Sep 26, 2024 |
| SPRINGER TIMOTHY A Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Jun 20, 2024 |
| MCGUIRE TERRANCE G Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Jun 20, 2024 |
| CORTIS CHRISTIAN Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| REICIN ALISE S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Jun 20, 2024 |
| TIPIRNENI PRAVEEN P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| VITOROVIC STEFAN Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Jun 20, 2024 |
| MCNAMARA PETER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| RUDDY MARCELLA KUHLMAN M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.23 - 1.30 per share. | Indirect | 971,493 | May 14, 2024 |
| AVRUCH STEVEN N. J.D. Officer | -- | Direct | -- | Feb 1, 2024 |
| OSTROWSKI ERIK Chief Executive Officer | -- | Direct | -- | Feb 1, 2024 |
| RIDHA ESSRA M.D. Officer | -- | Direct | -- | Feb 1, 2024 |
| GOLIPOUR AZADEH Chief Technology Officer | -- | Direct | -- | Feb 1, 2024 |
| MACKAY GEOFFREY Chief Executive Officer | Conversion of Exercise of derivative security at price 0.91 per share. | Direct | 41,859 | Jan 24, 2023 |
| MACKAY GEOFFREY Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 28, 2022 |
| MACKAY GEOFFREY Chief Executive Officer | Conversion of Exercise of derivative security at price 0.41 per share. | Direct | 58,680 | Dec 23, 2022 |
| VICKERS PHILIP J Director | Purchase at price 8.35 per share. | Direct | 40,080 | Jul 7, 2021 |
| DONENBERG PHILLIP BRIAN Director | Purchase at price 11.71 per share. | Direct | 23,420 | Feb 17, 2021 |
| MACKAY GEOFFREY Chief Executive Officer | Conversion of Exercise of derivative security at price 0.41 per share. | Direct | 41,320 | Dec 24, 2020 |
| MACKAY GEOFFREY Chief Executive Officer | Sale at price 29.07 per share. | Direct | 40,692 | Feb 12, 2020 |
| PAIGE CHRISTOPHER Director | Sale at price 28.00 per share. | Direct | 420,000 | Feb 11, 2020 |
| MACKAY GEOFFREY Chief Executive Officer | Sale at price 27.36 - 28.10 per share. | Direct | 1,737,081 | Feb 11, 2020 |
| PAIGE CHRISTOPHER Director | Sale at price 23.00 per share. | Direct | 230,000 | Jan 28, 2020 |
| MACKAY GEOFFREY Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Jul 29, 2019 |
| ATLAS VENTURE FUND LP Director | Purchase at price 18.50 per share. | Indirect | 15,000,004 | Jul 19, 2019 |
| ATLAS VENTURE FUND X, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 18.50 per share. | Indirect | 15,000,004 | Jul 19, 2019 |
| PAIGE CHRISTOPHER Director | Sale at price 25.59 - 26.92 per share. | Direct | 257,196 | Apr 8, 2019 |
| MACKAY GEOFFREY Chief Executive Officer | Sale at price 27.07 - 27.26 per share. | Direct | 381,511 | Apr 8, 2019 |
| OSTROWSKI ERIK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2019 |
| DORTON KATINA Chief Financial Officer | Conversion of Exercise of derivative security at price 0.91 per share. | Direct | 9,100 | Oct 8, 2018 |
| KREHER NERISSA C Officer | Conversion of Exercise of derivative security at price 0.91 per share. | Direct | 2,677 | Oct 8, 2018 |
| ATLAS VENTURE FUND LP Director | -- | Indirect | -- | Jun 25, 2018 |
| REQUADT SCOTT Director | -- | Indirect | -- | Jun 25, 2018 |
| CLARUS LIFESCIENCES III, L.P. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Jun 25, 2018 |
| SVLSF VI, L.L.C Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Jun 25, 2018 |
Related Tickers
KROS Keros Therapeutics, Inc.
14.15
+0.93%
CGEM Cullinan Therapeutics, Inc.
8.65
-0.40%
PHVS Pharvaris N.V.
16.60
-0.72%
NKTR Nektar Therapeutics
0.7245
-2.02%
VERA Vera Therapeutics, Inc.
18.95
-4.92%
THRD Third Harmonic Bio, Inc.
5.21
0.00%
ACTU Actuate Therapeutics, Inc. Common stock
11.90
+12.58%
TRML Tourmaline Bio, Inc.
16.68
+1.03%
EWTX Edgewise Therapeutics, Inc.
14.28
-1.99%
LXEO Lexeo Therapeutics, Inc.
2.7200
-5.23%